slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,138
Current window 62,461-62,490
Pages 2,605
Rows per page 30
Component
62,461-62,490 of 78,138
39
The slide uses donut charts to represent remission rates and highlights the safety advantages of Spyre's gut-selective approach.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
40
Includes a specific note that this is an 'Illustrative example' and 'Preliminary; pending regulatory feedback'.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
12
The slide uses bar charts to demonstrate performance relative to an 'unaffected date' related to a shareholder activist event.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations Beat · Future Vision (Gain)Loop · Before After1 hit
13
The slide highlights a 50% improvement in valuation multiple despite a decline in the NBI index multiple.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Before After1 hit
16
The slide uses a dual-axis timeline (top and bottom) to annotate events on a stock price chart.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & Proof1 hit
19
The slide uses a bar chart to show quarterly net sales growth from Q4'21 to Q1'23.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Mece Breakdown1 hit
23
The chart uses a break in the x-axis to transition from historical data (2020-2022) to future projections (2024-2025).Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
08
The slide uses a waterfall-style progression to show the growth of charging ports from existing to pipeline.Allego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · DesireLoop · Cost Of Inaction1 hit
07
The slide uses a central bar chart flanked by four strategic callout boxes.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · Key Takeaways1 hit
21
The chart uses a horizontal bar format to represent clinical trial stages (Preclinical to Commercial) for multiple indications, color-coded by therapeutic area (Neurology, Hematology/Rheumatology, Dermatology, Nephrology).argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations 1 hit
06
Includes primary endpoint noninferiority data and secondary responder metrics.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
13
The slide uses a pyramid layout to categorize indications by prevalence size, with green dots indicating successful proof-of-concept or Phase 3 data.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Market Sizing1 hit
12
Uses a 2D coordinate system to illustrate brand repositioning.Aston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations 1 hit
28
The chart uses IHS market forecast data to illustrate Aston Martin's strategic positioning in high-growth segments.Aston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations Beat · Problem1 hit
29
The chart illustrates a transition in powertrain technology over time.Aston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations Beat · Problem1 hit
32
The slide uses a scatter-plot style layout to imply a shift in product positioning.Aston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations Beat · Product1 hit
33
The chart displays dual Y-axes for Torque and Power, comparing two vehicle models across engine speed.Aston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations Beat · Product1 hit
60
Aston Martin Lagonda | Investor Day Presentation Deck | 66 slidesAston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations Beat · Financials1 hit
61
The chart uses a waterfall bridge format to explain margin expansion.Aston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations Beat · Financials1 hit
07
Includes a timeline of 5 years of Plenary Presentations.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
14
Includes Kaplan-Meier survival curve and 'number at risk' table.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
15
Clinical trial data visualization (Kaplan-Meier plot).AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
16
The slide displays a Kaplan-Meier survival analysis with a corresponding 'number at risk' table and key statistical metrics (HR, CI, p-value).AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
17
Standard forest plot used in clinical trial reporting.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
24
The chart is a diverging stacked bar chart comparing two treatment arms. Yellow boxes highlight specific hematological toxicities.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
34
The chart is a radial segment diagram showing patient population segments (HRD-negative, HRD-positive non-BRCAm, tBRCAm) and corresponding clinical trials.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
39
The slide includes a summary table at the bottom showing Median Duration of Response (DoR) for the three patient cohorts.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
40
The chart is a classic waterfall plot used in oncology clinical trials to visualize tumor shrinkage.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
41
The chart uses a grouped bar structure to compare IHC 3+ and IHC 2+ prevalence ranges across 8 cancer types.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
43
The slide illustrates the process of reweighting the ASCEND trial population to match the ALPINE trial population for a fair comparison.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit